Items Tagged ‘irinotecan’

May 12th, 2016

Avastin®/Camptosar® Improves Outcomes Compared with Temodar® in Glioblastoma

By

The treatment combination consisting of Avastin (bevacizumab) plus Camptosar (irinotecan) improves time to cancer progression compared to treatment with Temodar (temozolomide) in patients with newly diagnosed glioblastoma. These results were recently published in the Journal of Clinical Oncology. Glioblastoma is an extremely aggressive form of brain cancer. Standard therapy includes surgery to remove as much […]

View full entry

Tags: avastin, bevacizumab, Brain Cancer, Campostar, glioblastoma, irinotecan, News, nonmethylated O6-methylguanine–DNA methyltransferase promotor, Temodar, temozolomide


June 23rd, 2015

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment

By

Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs before they begin treatment, researchers at University of California, San Diego School of Medicine conducted a proof-of-principle study with a small group of metastatic colorectal […]

View full entry

Tags: Colon Cancer, colorectal cancer, irinotecan, metastatic, News, oxaliplatin, Rectal Cancer, Stage IV (D)/Relapsed Colon Cancer, Stage IV Rectal Cancer